U rinary Tract Infections (UTIs) are among the most common infections in both the out and inpatient settings. Increasing antimicrobial resistance of urinary pathogens has highlighted the need for reevaluation of the treatment options. [1] [2] [3] Since management of UTIs widely varies, these guidelines may help physicians choose cost-effective options. [4] [5] [6] [7] [8] [9] [10] Diagnosing a UTIs often requires examination of a urine sample in addition to clinical signs or symptoms (Table 1) . However, many guidelines indicate that a urine culture is not needed in most cases of uncomplicated lower UTI or cystitis. 11, 12 Escherichia coli remains the most common etiologic agent of community-acquired, uncomplicated UTIs, particularly in women under 50 years of age, with Staphylococcus saprophyticus the second commonest. For this reason, in treating uncomplicated cystitis, the first-line empiric antibiotic recommendations are those which are narrow-spectrum and used predominantly only for this indication.
Risk factors in UTIs
Factors of functional and anatomical alterations play the important role in the pathogenesis of UTIs. In women, the shortness of urethra, with its close proximity to the anus, makes it easy for bacteria to ascend the genito-urinary tract. Therefore, fecal-perinealurethral contamination is the most common cause of UTIs.
Altered vaginal flora (AVF) also plays a similar role in the pathogenesis of UTI in women. Lactobacilli is the dominant bacteria found in the vagina, possessing antimicrobial properties that regulate the local vaginal host defenses, by maintaining an acidic pH and producing hydrogen peroxide. The use of lactobacilluscontaining probiotics has been studied as a potential prophylactic for recurrent UTIs. However, the efficacy of this result of UTI prophylaxis remains as yet inconclusive. Alteration in vaginal flora can also be observed in UTIs occurring in postmenopausal women, because estrogen stimulates the proliferation of lactobacilli and reduces local pH. [13] [14] Pregnancy and UTIs.
Bacteriuria is the most common finding in pregnant women. Many studies have shown that upper UTI or acute pyelonephritis is more common in the second or third trimester of pregnant women with asymptomatic bacteriuria. For this reason asymptomatic bacteriuria in pregnant women has to be treated. 15, 16 
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Diabetes and UTIs
The risk of developing symptomatic UTI is increased in diabetes. 17 Asymptomatic bacteriuria is also increased in patients with diabetes over a longer duration. However studies showed only a weak correlation between increased risk of symptomatic UTIs and poor control of diabetes and microalbuminuria or macrovascular complications, also, antibiotic treatment did not decrease incidence of symptomatic UTI. 18, 19 Antibiotic treatment of UTIs 4, [21] [22] [23] An appropriate antibiotic varies according to the following information or criteria:
1 In many countries, where the uropathogen resistance to Trimetoprim-Sulfamethoxazole and Fluoroquinolone 
Term
Standard definition Application to management of urinary tract infection (UTI) in elderly patients
Significant bacteriuria Presence of a specified number (usually > 105 CFU/mL) of a single species of bacteria in freshly voided, midstream specimen of urine.
This level of bacteriuria is significant because it is unlikely that it can be explained by contamination of the urine sample with perineal flora. It DOES NOT indicate clinically significant bacteriuria. "Significant" bacteriuria is often asymptomatic and does not necessarily require treatment. Lower levels may sometimes be significant.
Uncomplicated urinary tract infection
Lower urinary tract infection in an adult woman who is not pregnant and has no underlying abnormality of the urinary tract or indwelling urinary device.
The evidence about effectiveness of short (3 day) courses of treatment for UTI only applies to uncomplicated UTIs. All UTIs in males, all UTIs associated with urinary catheters, and all UTIs with systemic symptoms are complicated UTIs.
Lower urinary tract infection Infection confined to the tissue of the bladder or urethra. The presence of symptoms or signs of systemic infection indicates upper urinary tract infection.
Both nitrofurantoin and fosfomycin only achieve effective concentrations in the lower urinary tract infection. These antibiotics should not be used to treat patients with systemic symptoms or signs.
is high, those agents may no longer be recommended for empiric treatment of UTI.
3. Fosfomycin trometamal, 3 gm sachet, in a single dose is an alternative for those with drug-resistant UTIs, but it appears to be less efficacious when compared with the standard 3-5 days regimen of other antibiotics according to data published.
23, 24
4. ß-lactam antibiotics, including Cephalosporin (2 nd or 3 rd generation), and betalactam-betalactamase inhibitors, such as amoxicillin-clavulanate/ampicillinsulbactam, in 3-7 days regimens are appropriate choices when other agents cannot be used. (B-III)
Antibiotic treatment for acute pyelonephritis
From a clinical point of view, acute pyelonephritis should be considered as tissue infection of the whole urinary tract; whereas an exact anatomical distinction on clinical grounds can often not be made. Blood and urine cultures should always be performed, and initial empirical intravenous antibiotic should be started as fast as possible, due to the somewhat higher incidence of bacteria in adult pyelonephritis. (A-III) Most patients with acute pyelonephritis require hospitalization and initially intravenously administered empiric antibiotics, such as cephalosporin, fluoroquinolone, aminoglycoside or carbapenem; the choice between these agents should be based on local resistance data. Later, the antibiotic regimen should be tailored on the basis of susceptibility results. 
Current Management of Urinary Tract Infections

Management of asymptomatic bacteriuria
Definition of asymptomatic bacteriuria 33, 34 1. Asymptomatic women, defined as 2 consecutive voided urine culture with isolation of the same bacteria, counts ≥ 10 5 CFU/ml (B-II) 2. A single, clean-catch voided urine of ≥ 10 5 CFU/ml (B-II) 3. A single catheterized urine of ≥ 10 5 CFU/ml in women or men (A-II) Asymptomatic bacteriuria is common in many groups of patients with indwelling catheters, where there is a very high prevalence of asymptomatic bacteriuria; such as in patients with spinal cord injury, where the prevalence ranges between 23-89. 35 Studies have shown that it is worth treating asymptomatic bacteriuria only in pregnant women and patients in whom a urinary tract intervention is intended that may be expected to damage the mucosa.
Conclusion
Urinary tract infections are responsible for a large proportion of antibiotic administrations; bacterial resistance is increasing. For this reason, in treating UTIs, treatment recommendation should take into account to the efficacy of the antibiotics and also, especially factors relating to their sustainability. Asymptomatic bacteriuria should only be treated in a few exceptional cases, such as during pregnancy or before genitourinary tract interventions.
The appropriacy of the initial or empirical antibiotic for acute pyelonephritis also depends on the severity of illness at presentation as well as local resistance and comorbidity of patients, and host factors.
For some areas of the world, including Thailand, the prevalence of Fluoroquinolone resistance exceeds 10%; therefore the generally recommended initial antibiotic is a parenteral 3 rd generation long-acting cephalosporin, normally ceftriaxone.
Duration of antibiotic therapy for lower UTI
A 3-day course of highly effective antibiotics or tissue-directed antibiotic such as Trimethoprim-Sulfame thoxazole and Fluoroquinolone, is recommended for women and a 7-day course for men. 25 If ß-lactam is used, the duration recommended is 5 days for women, of all ages.
Duration of antibiotic therapy for upper UTI-(acute pyelonephritis)
Most published guidelines recommend a 14 days regimen (A-I), 4, 26-30 however a 7-10 days regimen is also recommended if a highly active agent, such as Fluoroquinolone, is used.
Recently, the Infectious Diseases Society of America in collaboration with the European Society for Microbiology and Infectious Diseases (ESCMID) have systematically updated ISDA clinical practice guidelines for treating acute uncomplicated cystitis and pyelonephritis in women. (Table 2 
